The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated results from CHAMPION-1, a phase I/II study investigating weekly carfilzomib with dexamethasone for patients (Pts) with relapsed or refractory multiple myeloma (RRMM).
 
James R. Berenson
Honoraria - Onyx
Consulting or Advisory Role - Onyx
Research Funding - Onyx
Travel, Accommodations, Expenses - Onyx
 
Alan Cartmell
No Relationships to Disclose
 
Alberto Bessudo
No Relationships to Disclose
 
Roger M. Lyons
Employment - McKesson; US Oncology
Honoraria - Amgen; Incyte
Consulting or Advisory Role - Amgen; Incyte
Travel, Accommodations, Expenses - Amgen; Incyte
 
Wael A. Harb
Consulting or Advisory Role - Onyx
Research Funding - Horizon Oncology Research (Inst)
 
Dimitrios Tzachanis
No Relationships to Disclose
 
Morton Coleman
No Relationships to Disclose
 
Ralph V. Boccia
Honoraria - Amgen; Celgene; Eisai; Genentech
Consulting or Advisory Role - bioTheranostics
Speakers' Bureau - bioTheranostics
 
Robert M. Rifkin
Consulting or Advisory Role - Amgen; Celgene; Millennium; onyx; Takeda
 
Priti Patel
Employment - Onyx
 
Sandra Dixon
Employment - Onyx
 
Jesus G. Berdeja
Research Funding - Bristol-Myers Squibb; Celgene; MEI Pharma; Onyx; Takeda